350 related articles for article (PubMed ID: 25870085)
41. BEAC or BEAM high-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma patients: comparative analysis of efficacy and toxicity.
Jo JC; Kang BW; Jang G; Sym SJ; Lee SS; Koo JE; Kim JW; Kim S; Huh J; Suh C
Ann Hematol; 2008 Jan; 87(1):43-8. PubMed ID: 17710401
[TBL] [Abstract][Full Text] [Related]
42. [High-dose etoposide with granulocyte colony-stimulating factor for mobilization of autologous peripheral blood stem/progenitor cells in patients with hematologic malignancies].
Lu H; Li JY; Ge Z; Liu P; Wu YJ; Wu HX; Zhang XY; Qian SX; Hong M; Zhang R
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):397-9. PubMed ID: 16638224
[TBL] [Abstract][Full Text] [Related]
43. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
Lemoli RM; Cavo M; Fortuna A
J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709
[TBL] [Abstract][Full Text] [Related]
44. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918
[TBL] [Abstract][Full Text] [Related]
45. Prospective randomized comparative observation of single- versus split-dose lenograstim to enhance engraftment after autologous stem cell transplantation in patients with multiple myeloma or non-Hodgkin's lymphoma.
Jang G; Ko OB; Kim S; Lee DH; Huh J; Suh C
Transfusion; 2008 Apr; 48(4):640-6. PubMed ID: 18194384
[TBL] [Abstract][Full Text] [Related]
46. High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma.
Kumar L; Raju GM; Ganessan K; Shawgi S; Menon H; Wadhwa J; Sharma A; Singh R; Kochupillai V
Natl Med J India; 2003; 16(1):16-21. PubMed ID: 12715951
[TBL] [Abstract][Full Text] [Related]
47. Risk factors before autologous stem-cell transplantation for lymphoma predict for secondary myelodysplasia and acute myelogenous leukemia.
Kalaycio M; Rybicki L; Pohlman B; Sobecks R; Andresen S; Kuczkowski E; Bolwell B
J Clin Oncol; 2006 Aug; 24(22):3604-10. PubMed ID: 16877727
[TBL] [Abstract][Full Text] [Related]
48. Double high-dose therapy for Hodgkin's disease with dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP) prior to high-dose melphalan and autologous stem cell transplantation.
Stewart DA; Guo D; Glück S; Morris D; Chaudhry A; deMetz C; Klassen J; Brown CB; Russell JA
Bone Marrow Transplant; 2000 Aug; 26(4):383-8. PubMed ID: 10982284
[TBL] [Abstract][Full Text] [Related]
49. Intraoperative Anemia and Single Red Blood Cell Transfusion During Cardiac Surgery: An Assessment of Postoperative Outcome Including Patients Refusing Blood Transfusion.
Hogervorst EK; Rosseel PM; van de Watering LM; Brand A; Bentala M; van der Bom JG; van der Meer NJ
J Cardiothorac Vasc Anesth; 2016 Apr; 30(2):363-72. PubMed ID: 26809765
[TBL] [Abstract][Full Text] [Related]
50. Jehovah's Witness Patients: Interventions for Successful Stem Cell Transplantation Without Blood Product Transfusions for Hematologic Malignancies.
Park A; Rome S; Gantioque R
Clin J Oncol Nurs; 2019 Aug; 23(4):364-369. PubMed ID: 31322623
[TBL] [Abstract][Full Text] [Related]
51. [Experience in kidney transplantation without blood transfusion: kidney transplantation transfusion-free in Jehovah's Witnesses. First communication in Mexico].
Hernández-Navarrete LS; Hernández-Jiménez JD; Jiménez-López LA; Budar-Fernández LF; Méndez-López MT; Martínez-Mier G
Cir Cir; 2013; 81(5):450-3. PubMed ID: 25125065
[TBL] [Abstract][Full Text] [Related]
52. Safety and survival outcomes for bloodless transplantation in patients with myeloma.
Joseph NS; Kaufman JL; Boise LH; Valla K; Almaula DK; Obidike CO; Langston AA; Waller EK; Khoury HJ; Flowers CR; Graiser M; Heffner LT; Lonial S; Nooka AK
Cancer; 2019 Jan; 125(2):185-193. PubMed ID: 30480777
[TBL] [Abstract][Full Text] [Related]
53. Successful autologous peripheral blood stem cell transplantation in a Jehovah's Witness with multiple myeloma: review of literature and recommendations for high-dose chemotherapy without support of allogeneic blood products.
Schmitt S; Mailaender V; Egerer G; Leo A; Becker S; Reinhardt P; Wiesneth M; Schrezenmeier H; Ho AD; Goldschmidt H; Moehler TM
Int J Hematol; 2008 Apr; 87(3):289-97. PubMed ID: 18317881
[TBL] [Abstract][Full Text] [Related]
54. A protocol avoiding allogeneic transfusion in joint arthroplasties.
Suh YS; Nho JH; Choi HS; Ha YC; Park JS; Koo KH
Arch Orthop Trauma Surg; 2016 Sep; 136(9):1213-1226. PubMed ID: 27450193
[TBL] [Abstract][Full Text] [Related]
55. Management of injured patients who were Jehovah's Witnesses, where blood transfusion may not be an option: a retrospective review.
Olaussen A; Bade-Boon J; Fitzgerald MC; Mitra B
Vox Sang; 2018 Apr; 113(3):283-289. PubMed ID: 29392737
[TBL] [Abstract][Full Text] [Related]
56. Is There Sufficient Evidence Justifying Limited Access of Jehovah's Witness Patients to Kidney Transplantation?
Carvalho Fiel D; Nunes Ficher K; Bernardi Taddeo J; Linhares Silva K; Rosso Felipe C; Aguiar W; Daniel Braz Cardone J; Foresto RD; Tedesco-Silva H; Medina-Pestana J
Transplantation; 2021 Jan; 105(1):249-254. PubMed ID: 33350627
[TBL] [Abstract][Full Text] [Related]
57. Administration of recombinant human erythropoietin alpha before autologous stem cell transplantation reduces transfusion requirement in multiple myeloma patients.
Martino M; Oliva E; Console G; Stelitano C; Fujo M; Messina G; Irrera G; Pucci G; Mandaglio R; Callea V; Nobile F; Iacopino P; Morabito F
Support Care Cancer; 2005 Mar; 13(3):182-7. PubMed ID: 15480819
[TBL] [Abstract][Full Text] [Related]
58. Bloodless tandem autologous transplant in Jehovah's Witness patients.
Khan R; Mott SL; Schultz A; Jethava YS; Tricot G
Bone Marrow Transplant; 2018 Nov; 53(11):1428-1433. PubMed ID: 29795417
[TBL] [Abstract][Full Text] [Related]
59. Risk factors for development of pneumonitis after high-dose chemotherapy with cyclophosphamide, BCNU and etoposide followed by autologous stem cell transplant.
Lane AA; Armand P; Feng Y; Neuberg DS; Abramson JS; Brown JR; Fisher DC; LaCasce AS; Jacobsen ED; McAfee SL; Spitzer TR; Freedman AS; Chen YB
Leuk Lymphoma; 2012 Jun; 53(6):1130-6. PubMed ID: 22132836
[TBL] [Abstract][Full Text] [Related]
60. Peri-operative blood management of Jehovah's Witnesses undergoing cytoreductive surgery for advanced ovarian cancer.
Palaia I; Caruso G; Di Donato V; Perniola G; Ferrazza G; Panzini E; Scudo M; Di Pinto A; Muzii L; Panici PB
Blood Transfus; 2022 Mar; 20(2):112-119. PubMed ID: 35244533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
